Saturday, January 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Outbreak News

CDC Updates Monkeypox Travel Alert for Nigeria

by Global Biodefense Staff
February 7, 2020
CDC Updates Monkeypox Travel Alert for Nigeria

This image was created during a investigation into an outbreak of monkeypox, which took place in the Democratic Republic of the Congo (DRC), 1996 to 1997, formerly Zaire, and depicts the dorsal surfaces of monkeypox case patient, who was displaying the appearance of the characteristic rash during its recuperative stage. Credit: CDC

The U.S. Centers for Disease Control and Prevention (CDC) updates an existing Level 1 Travel Alert for Monkeypox in the Federal Republic of Nigeria

There is an ongoing outbreak of Monkeypox in Nigeria, resulting in over 50 confirmed cases in 2019.On October 18, 2018, CDC issued a Travel Notice for Monkeypox in Nigeria. This notice was updated recently to reflect the current status. Additionally, the Nigeria Center for Disease Control (NCDC) has reported five cases of Monkeypox in travelers with recent travel history from Nigeria to the UK (3), Singapore (1) and Israel (1).

  • Level 1 Travel Notice for Monkeypox

Lassa fever is caused by a virus carried by rodents, most often in rural areas or areas with poorly constructed housing. Given the current outbreak in Nigeria, you should avoid contact with rodents, and seek medical care if you develop a fever or “flu symptoms”.

Level 1 Travel Notice for Lassa Fever

Yellow fever vaccination is a “must” before travel to Nigeria. Your yellow card showing vaccination status will be checked on arrival.

  • Level 2 Travel Notice for Yellow Fever

Actions to Take:

  • Check that your international medical and evacuation insurance is current.
  • Visit the CDC Travelers’ Health Pageand the CDC Travel Notices on Yellow Fever, Monkeypox, and Lassa Fever in Nigeria, which has information on this outbreak and advice on further steps to take.
  • See the State Department’s travel websiteand Country Specific Information for Nigeria
  • Take necessary precautions described on the CDC’s website to avoid infection, especially if visiting rural or rainforest areas
  • Seek immediate medical care OR contact a doctor right away if you become ill with a blistering rash.
  • Monitor local media and NCDC website for updates.
  • Regularly visit the CDC Travelers Health Page.
  • Consult the U.S. Centers for Disease Control and Prevention for country health advisories, or call CDC at 800-232-4636 or 404-639-3534.

Assistance:

  • U.S. Embassy in Abuja, Nigeria
    +(234) 9 461-4000
    AbujaACS@state.gov
  • S. Consulate in Lagos, Nigeria
    +(234) 1 460-3400
    LagosACS@state.gov
  • State Department – Consular Affairs
    888-407-4747 or 1-202-501-4444
  • Nigeria Country Information
  • Enroll in the Smart Traveler Enrollment Program (STEP) to receive security updates.
Tags: Lassa FeverMagazine Edition 20 Feb 2020MonkeypoxPoxvirusesYellow Fever

Related Posts

Officials Declare End to Ebola Outbreak in Uganda
Infectious Diseases

Officials Declare End to Ebola Outbreak in Uganda

January 11, 2023
A mother comforts her ill child and holds a hand to her forehead to test for temperature
Outbreak News

Strep A and Scarlet Fever: Signs and Symptoms

December 7, 2022
dressed head to toe in protective suit and gloves, a worker places a dropper of liquid onto a small plastic device to test for Ebola virus
Outbreak News

How Prepared is Uganda for the Current Ebola Outbreak?

September 24, 2022
Small Cluster of Pneumonia Cases in Argentina Identified as Legionella
Outbreak News

Small Cluster of Pneumonia Cases in Argentina Identified as Legionella

September 5, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC